VASCULAR DISEASES
Clinical trials for VASCULAR DISEASES explained in plain language.
Never miss a new study
Get alerted when new VASCULAR DISEASES trials appear
Sign up with your email to follow new studies for VASCULAR DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Doulas and smart devices team up to tackle postpartum hypertension
Disease control OngoingThis study tests whether adding a specially trained doula, along with home blood pressure and weight monitoring, can improve blood pressure in women who had high blood pressure during pregnancy. About 454 women will be randomly assigned to usual care or the doula program. The goa…
Matched conditions: VASCULAR DISEASES
Phase: NA • Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Supplement shows promise for kidney Patients' heart health
Disease control OngoingThis study tests whether a natural supplement called nicotinamide riboside can improve artery stiffness and lower blood pressure in people with moderate to severe chronic kidney disease. About 118 adults aged 35-80 will take either the supplement or a placebo for 3 months. The go…
Matched conditions: VASCULAR DISEASES
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could zapping kidney nerves tame tough high blood pressure?
Disease control OngoingThis study tests a device that uses radiofrequency energy to calm overactive kidney nerves, which can drive high blood pressure. About 1,900 adults with uncontrolled hypertension will receive the procedure and be followed for years. The goal is to see if this approach safely and …
Matched conditions: VASCULAR DISEASES
Phase: NA • Sponsor: Medtronic Vascular • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Zapping kidney nerves could tame tough blood pressure
Disease control OngoingThis study tests a device that uses ultrasound to disrupt overactive nerves in the kidneys, which can drive high blood pressure. About 282 adults with hypertension will either get the real procedure or a sham (fake) procedure. The goal is to see if this treatment safely lowers bl…
Matched conditions: VASCULAR DISEASES
Phase: NA • Sponsor: ReCor Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can pushing blood pressure lower save stroke Survivors' hearts?
Disease control OngoingThis study tests whether a very low blood pressure target (below 120 mmHg) can prevent major heart problems in people who have had a stroke or mini-stroke. About 4,300 participants are randomly assigned to either intensive or standard blood pressure control and followed for about…
Matched conditions: VASCULAR DISEASES
Phase: NA • Sponsor: Hospital Israelita Albert Einstein • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Sound waves vs. high blood pressure: new device shows promise
Disease control OngoingThis study tests a device called Paradise™ that uses ultrasound to calm overactive nerves in the kidneys, which can drive high blood pressure. Researchers will compare the device to a sham (fake) procedure in 154 adults with hypertension who are already taking two blood pressure …
Matched conditions: VASCULAR DISEASES
Phase: NA • Sponsor: Otsuka Medical Devices Co., Ltd. Japan • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Heart stent showdown: which device works best for blocked arteries?
Disease control OngoingThis study compares two types of stents (small mesh tubes) used to open blocked heart arteries in people with severe three-vessel coronary artery disease. About 1,550 participants will receive either the SUPRAFLEX Cruz or SYNERGY stent. The goal is to see which stent is safer and…
Matched conditions: VASCULAR DISEASES
Phase: NA • Sponsor: National University of Ireland, Galway, Ireland • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New inhaled drug aims to ease lung scarring and heart strain
Disease control OngoingThis Phase 2 trial tests an inhaled medication called mosliciguat in 135 people who have both lung scarring (interstitial lung disease) and high blood pressure in the lungs. Participants are randomly assigned to receive either the drug or a placebo for 16 weeks. The study measure…
Matched conditions: VASCULAR DISEASES
Phase: PHASE2 • Sponsor: Pulmovant, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New hope for PAH patients: Long-Term drug safety trial opens
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of the drug ralinepag in people with pulmonary arterial hypertension (PAH), a serious lung condition that makes it hard to breathe. About 1,000 adults who were in earlier ralinepag studies can join. The goal is to see if the drug remains s…
Matched conditions: VASCULAR DISEASES
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New Clot-Busting device could save lives in pulmonary embolism
Disease control OngoingThis trial is testing a device called the Aventus Thrombectomy System, which suctions out blood clots from the lungs in people with acute pulmonary embolism. The study involves 130 participants aged 18 to 80. The goal is to see if the device is safe and effective at improving blo…
Matched conditions: VASCULAR DISEASES
Phase: NA • Sponsor: Inquis Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Desperate patients get access to experimental Lab-Made vessel
Disease control TEMPORARILY_NOT_AVAILABLEThis program allows individual patients with vascular disease or end-stage kidney disease on dialysis to request an experimental lab-grown blood vessel (ATEV) if they have no other treatment options and cannot join a clinical study. The vessel is designed to replace or bypass dam…
Matched conditions: VASCULAR DISEASES
Sponsor: Humacyte, Inc. • Aim: Disease control
Last updated Jun 26, 2026 17:08 UTC
-
Virtual doctor visits tested for vascular care – but study never started
Knowledge-focused TerminatedThis study planned to compare virtual clinic visits (using video calls on tablets) with in-person visits for people with vascular diseases. Doctors would classify patients as low, moderate, or high risk for treatment after each visit type. The goal was to see if virtual visits co…
Matched conditions: VASCULAR DISEASES
Phase: NA • Sponsor: CAMC Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Heart drug study cancelled before it began
Knowledge-focused TerminatedThis study was designed to see if a cholesterol-lowering drug called a PCSK9 inhibitor could also reduce inflammation in the arteries of people with heart disease. Researchers planned to use a special imaging scan to measure inflammation. The study was withdrawn before enrolling …
Matched conditions: VASCULAR DISEASES
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Hospital study on vascular admissions withdrawn before starting
Knowledge-focused TerminatedThis study aimed to create a 12-month profile of patients admitted for vascular surgery at University Hospital Limerick in Ireland. The goal was to understand patient characteristics like frailty and other health conditions to improve hospital services and reduce length of stay. …
Matched conditions: VASCULAR DISEASES
Sponsor: University Hospital of Limerick • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:58 UTC
-
Diet study for surgery patients withdrawn before starting
Knowledge-focused TerminatedThis study was designed to see if a short-term protein-calorie restriction diet before elective vein graft surgery is practical and how it affects the body. It planned to enroll adults scheduled for non-emergency lower extremity vein bypass surgery. However, the trial was withdra…
Matched conditions: VASCULAR DISEASES
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:48 UTC